Raymond James upgraded to Nutrien (NYSE:NTR) to Outperform from Market Perform with an $85 per share price target in a note Friday.
On Wednesday, Nutrien reported earnings data, with its Q1 EPS of $1.11, $0.40 worse than the analyst estimate of $1.51. Revenue for the quarter came in at $6.11 billion versus the consensus estimate of $6.39 billion.
Raymond James analysts told investors the miss was tough, but farmer demand is re-emerging, and they see an attractive entry point.
There are "increased signs of: 1) farmer engagement/procurement after a lengthy period of dormancy; 2) depleting NPK inventories across key channels; 3) gradual stabilization in key price benchmarks; and 4) most recently, a widespread flush of Street/ investor expectations following NTRs 1Q23 print," wrote the analysts.
"While still too early to 'call the bottom' on this geopolitically-entangled, weather-amplified cycle, we feel that the recent pullback in NTR shares provides an attractive entry point for long-term investors."
Should you invest $2,000 in NTR right now?
With NTR making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of overpriced darlings, identifying true value can be challenging. InvestingPro's advanced AI algorithms have analyzed NTR alongside thousands of other stocks to uncover hidden gems. These undervalued stocks, potentially including NTR, could offer substantial returns as the market corrects. In 2024 alone, our AI identified several undervalued stocks that later surged by 30 or more. Is NTR poised for similar growth? Don't miss the opportunity to find out.
Reveal Undervalued Stocks Now